Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11
Original Research
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
927 | Dovepress* | 878+ | 20 | 898 | |
PubMed Central* | 49 | 21 | 70 | ||
Totals | 927 | 41 | 968 | ||
*Since 4 March 2024 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
10 | 0 | 0 | 0 | 5 | 5 |
View citations on PubMed Central and Google Scholar